View : 874 Download: 223
Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes
- Title
- Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes
- Authors
- Kim, Jong-Han; Huh, Yeon-Ju; Park, Susan; Park, Young Suk; Park, Joong; Kwon, Jin-Won; Lee, Joo Ho; Heo, Yoon Seok; Choi, Seung Ho
- Ewha Authors
- 이주호; 허연주
- SCOPUS Author ID
- 이주호; 허연주
- Issue Date
- 2020
- Journal Title
- ASIAN JOURNAL OF SURGERY
- ISSN
- 1015-9584
0219-3108
- Citation
- ASIAN JOURNAL OF SURGERY vol. 43, no. 1, pp. 297 - 303
- Keywords
- Type II DM; Gastric cancer; Long limb Roux-en Y
- Publisher
- ELSEVIER SINGAPORE PTE LTD
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background/Objective: The number of gastric cancer and type II diabetes mellitus is increasing in Korea. Metabolic surgery could be extended to gastric cancer patients with type II diabetes, especially those who are expected to achieve long-term survival. This study aimed to investigate change of diabetic status in patients undergoing long-limb Roux-en-Y bypass reconstruction compared with conventional Billroth II after curative gastrectomy. In total, 130 patients from five university hospital centers underwent long-limb Roux-en Y reconstruction after radical distal gastrectomy. Methods: In the long-limb group, the length of biliopancreatic limbs was more than 80 cm, and the length of the Roux limb was more than 80 cm. The control group comprised 96 patients who underwent conventional Billroth II reconstruction after distal gastrectomy. Follow-up data at three, six, nine, and 12 months were compared between the two groups. Results: Fasting blood sugar (FBS) and hemoglobin (Hb) A1c levels decreased more significantly in the long-limb Roux-en-Y group (FBS: 28.8 mg/dL; HbA1c: 0.72%). However, decreases in body mass index, albumin, and hemoglobin did not differ significantly between the two groups. Diabetes control significantly improved in the long-limb group. In multivariate analysis, long-limb bypass reconstruction was the significant factor for glycemic outcomes. Conclusion: Roux-en-Y bypass with increased length of limbs after gastrectomy shows a favorable glycemic control for gastric cancer patients with type II diabetes without nutritional deficit and anemia. To obtain future perspectives, large-scale prospective studies with long-term outcomes are needed. (C) 2019 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.
- DOI
- 10.1016/j.asjsur.2019.03.018
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
-
Multicenter results.pdf(588.91 kB)
Download
- Export
- RIS (EndNote)
- XLS (Excel)
- XML